Markku Miettinen
Markku Miettinen publishes mostly in Pulmonary and Respiratory Medicine, Rheumatology and Oncology, on topics such as Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment and Soft tissue tumor case studies.
- World rank
- #6,392 of 7,710,434 ranked researchers
- Rank in United States
- #2,205 of 1,627,098
- Works
- 877
- Citations
- 58k
- Citations per work
- 66.4
What does Markku Miettinen research?
Markku Miettinen's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences47654.3%
- Medicine47654.3%
- Everything else34539.3%
- Life Sciences566.4%
- 1Pulmonary and Respiratory Medicine20% of their works
- 2Rheumatology10% of their works
- 3Oncology10% of their works
- 4Surgery9% of their works
- 5Gastroenterology6% of their works
- 6Molecular Biology6% of their works
Research topics
Which keywords describe Markku Miettinen's research?
The keywords of their largest research topics: Prognostic Factors, Osteosarcoma, Soft Tissue Sarcoma, Imatinib Mesylate, Sunitinib, Desmoid Tumor, Solitary Fibrous Tumor and Neurofibromatosis.
- Cardiac Tumors
- Intussusception
- Granular Cell Tumor
- Angiosarcoma
- Neurofibromatosis
- Desmoid Tumor
- Imatinib Mesylate
- Osteosarcoma
- Prognostic Factors
- Soft Tissue Sarcoma
- Sunitinib
- Solitary Fibrous Tumor
- Tumor Suppressor
- Epithelioid Hemangioendothelioma
- Immunohistochemical Assessment
- Meckel's Diverticulum
- PRKAR1A Gene Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Prognostic Factors4393 topics
- Osteosarcoma2311 topic
- Soft Tissue Sarcoma2311 topic
- Imatinib Mesylate1181 topic
- Sunitinib1181 topic
- Desmoid Tumor901 topic
- Solitary Fibrous Tumor901 topic
- Neurofibromatosis751 topic
- Tumor Suppressor751 topic
- Angiosarcoma611 topic
- Epithelioid Hemangioendothelioma611 topic
- Granular Cell Tumor461 topic
- Immunohistochemical Assessment461 topic
- Intussusception441 topic
- Meckel's Diverticulum441 topic
- Cardiac Tumors391 topic
- PRKAR1A Gene Mutations391 topic
Where does Markku Miettinen work?
Markku Miettinen's main affiliation in the publication record is National Cancer Institute, United States.
How many publications and citations does Markku Miettinen have?
OpenAlex counts 877 works and 58,257 citations for Markku Miettinen, an h-index of 123, ranking #6,392 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Markku Miettinen
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Markku Miettinen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.